John Fisher, associate professor in the Fischell Department of Bioengineering, won the Best Inventor Pitch at the 2009 Bioscience Research and Technology Review Day with a tissue engineering bioreactor system that grows bone and other types of tissue for implantation.

NOVAVAX (Nasdaq: NVAX) and Vivalis (NYSE Euronext: VLS) announced the completion of a research license to use the Vivalis proprietary EB66(R) cell line, for the production of Novavax VLP based vaccines. Through this collaboration, Novavax intends to test the EB66(R) cell line for the production of VLP vaccines against several new potential viruses.

Researchers have combined the efforts of two kinds of bacteria to produce hydrogen in a bioreactor, with the product from one providing food for the other. According to an article in the August issue of Microbiology Today, this technology has an added bonus: leftover enzymes can be used to scavenge precious metals from spent automotive [...]